ArticleNeuro-oncology advances

A phase 2 study of niraparib concomitant with tumor treating fields in patients with recurrent grade 4 glioma.

Elizabeth C Cordell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.